Nestlé’s $1B VMS Sale: What the Yellow Wood Deal Signals for the Supplement Market

Nestlé has agreed to sell its mainstream vitamins, minerals, and supplements (VMS) business to Yellow Wood Partners for US$1.0 billion. The split of the portfolio tells us more about the direction of the vitamin, mineral and supplement market.

Nestlé retains Solgar and Pure Encapsulations, concentrating on what it calls premium, science-led VMS. Yellow Wood acquires the Holistic Health portfolio, including Nature’s Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan’s Pride and Sisu, along with the associated U.S. private-label supplements business and dedicated manufacturing, packaging, warehousing, and distribution operations.

Nestlé reports that the business generated US$1.2 billion in sales in 2025. Closing is expected by the first half of 2027, subject to applicable regulatory approvals.

Three observations stand out:

1. Household reach is table stakes, not a moat

Yellow Wood describes Nature’s Bounty as the #2 VMS brand in the U.S., consumed in more than 20% of American households. That is real reach.

It still wasn’t enough to keep the mainstream portfolio inside Nestlé’s chosen strategic focus. In a crowded supplement market, familiarity has to convert into growth, margin, and a claim on capital.

2. Read the buyer’s release closely

Yellow Wood names Nature’s Bounty and highlights Nuun, Osteo Bi-Flex, and Gard among the platform’s specialty brands. Puritan’s Pride, Ester-C, and Sisu get no comparable emphasis.

That proves nothing on its own, but it’s worth reading against the review. When it was reported in July 2025, Nestlé pointed to weaker performance among its mainstream brands, and Puritan’s Pride in particular, alongside the discontinuation of some private-label business.

This isn’t a uniform portfolio, and the investment behind it may not be uniform either.

3. Supply-chain capability moved too

The private-label business and dedicated operations transfer alongside the brands.

Yellow Wood identifies hydration, gut health, and immunity as opportunity areas and presents standalone ownership as the route to faster growth and innovation. For anyone supplying or competing with this portfolio, both the shelf and the supply base are now in play.

VMS M&A is revealing a more important dividing line

Three VMS agreements in four weeks, and the dividing line isn’t simply premium versus mass.

P&G agreed to acquire Thorne, reported at US$3.8 billion. Kirin agreed to acquire Jamieson Wellness, whose branded segment revenue grew 15.6% in fiscal 2025. Both are strategic buyers taking platforms that were still compounding.

Nestlé’s mainstream portfolio went to a financial buyer after parts of it had been identified as the weaker performers.

Trajectory may be the more useful dividing line than tier

For suppliers, the more important question may therefore be less about which tier their customers occupy and more about whether those customers are still growing.

One is visible from positioning and price. The other requires a much deeper understanding of brand performance, channel dynamics, and the supply base behind them. That is increasingly where our client conversations begin.

Want to understand what these shifts could mean for your business? Connect with our team to explore the implications across brands, channels and the VMS supply base.

Smart Data. Trusted Expertise. Better Decisions.